

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 9.82209524 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 9.72345607 |
| 3 | angiotensin maturation (GO:0002003) | 8.39576094 |
| 4 | maintenance of gastrointestinal epithelium (GO:0030277) | 7.65683813 |
| 5 | positive regulation of respiratory burst (GO:0060267) | 7.31669451 |
| 6 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.56177417 |
| 7 | hemidesmosome assembly (GO:0031581) | 6.02378798 |
| 8 | bile acid and bile salt transport (GO:0015721) | 5.93318510 |
| 9 | epithelial structure maintenance (GO:0010669) | 5.90075154 |
| 10 | virion attachment to host cell (GO:0019062) | 5.89979255 |
| 11 | adhesion of symbiont to host cell (GO:0044650) | 5.89979255 |
| 12 | complement activation, classical pathway (GO:0006958) | 5.84638673 |
| 13 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.72570061 |
| 14 | actin filament depolymerization (GO:0030042) | 5.68434273 |
| 15 | digestive system process (GO:0022600) | 5.59409976 |
| 16 | regulation of cellular extravasation (GO:0002691) | 5.50456375 |
| 17 | glomerular filtration (GO:0003094) | 5.37090480 |
| 18 | vitamin A metabolic process (GO:0006776) | 5.28907766 |
| 19 | regulation of RIG-I signaling pathway (GO:0039535) | 5.24047348 |
| 20 | antibacterial humoral response (GO:0019731) | 5.21278571 |
| 21 | antimicrobial humoral response (GO:0019730) | 5.11323106 |
| 22 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.10650324 |
| 23 | renal filtration (GO:0097205) | 5.02348870 |
| 24 | regulation of respiratory burst (GO:0060263) | 4.90886125 |
| 25 | regulation of bile acid biosynthetic process (GO:0070857) | 4.84164860 |
| 26 | adhesion of symbiont to host (GO:0044406) | 4.79579203 |
| 27 | O-glycan processing (GO:0016266) | 4.74015431 |
| 28 | complement activation (GO:0006956) | 4.64859918 |
| 29 | positive regulation of pseudopodium assembly (GO:0031274) | 4.55952944 |
| 30 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.44286348 |
| 31 | regulation of viral release from host cell (GO:1902186) | 4.36397583 |
| 32 | intestinal epithelial cell development (GO:0060576) | 4.34119525 |
| 33 | modified amino acid transport (GO:0072337) | 4.30916065 |
| 34 | glucocorticoid biosynthetic process (GO:0006704) | 4.30050990 |
| 35 | drug catabolic process (GO:0042737) | 4.26208366 |
| 36 | regulation of guanylate cyclase activity (GO:0031282) | 4.19718605 |
| 37 | cGMP-mediated signaling (GO:0019934) | 4.08462367 |
| 38 | regulation of pseudopodium assembly (GO:0031272) | 4.06940404 |
| 39 | arginine catabolic process (GO:0006527) | 4.03176796 |
| 40 | hepatocyte apoptotic process (GO:0097284) | 3.90363425 |
| 41 | digestion (GO:0007586) | 3.89906249 |
| 42 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.84029232 |
| 43 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.84029232 |
| 44 | transcytosis (GO:0045056) | 3.80405933 |
| 45 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.79635380 |
| 46 | response to hepatocyte growth factor (GO:0035728) | 3.79635380 |
| 47 | oligosaccharide biosynthetic process (GO:0009312) | 3.78187268 |
| 48 | flavonoid metabolic process (GO:0009812) | 3.74455313 |
| 49 | desmosome organization (GO:0002934) | 3.72393341 |
| 50 | diacylglycerol metabolic process (GO:0046339) | 3.68716026 |
| 51 | cobalamin metabolic process (GO:0009235) | 3.65664076 |
| 52 | fucose catabolic process (GO:0019317) | 3.64625131 |
| 53 | L-fucose metabolic process (GO:0042354) | 3.64625131 |
| 54 | L-fucose catabolic process (GO:0042355) | 3.64625131 |
| 55 | sulfation (GO:0051923) | 3.63418913 |
| 56 | glucose 6-phosphate metabolic process (GO:0051156) | 3.62551626 |
| 57 | drinking behavior (GO:0042756) | 3.62099938 |
| 58 | thrombin receptor signaling pathway (GO:0070493) | 3.58256932 |
| 59 | protein activation cascade (GO:0072376) | 3.57877632 |
| 60 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.53558789 |
| 61 | peptide catabolic process (GO:0043171) | 3.52272191 |
| 62 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.51103494 |
| 63 | arginine metabolic process (GO:0006525) | 3.50462610 |
| 64 | defense response to fungus (GO:0050832) | 3.49957522 |
| 65 | sulfate transmembrane transport (GO:1902358) | 3.47763395 |
| 66 | sulfur compound transport (GO:0072348) | 3.46214735 |
| 67 | lipoprotein metabolic process (GO:0042157) | 3.43527892 |
| 68 | regulation of cholesterol homeostasis (GO:2000188) | 3.40762370 |
| 69 | striated muscle atrophy (GO:0014891) | 3.39034712 |
| 70 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.37057765 |
| 71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.35802810 |
| 72 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.33665380 |
| 73 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.31571576 |
| 74 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.28750612 |
| 75 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.20205153 |
| 76 | plasma lipoprotein particle assembly (GO:0034377) | 3.19489335 |
| 77 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.17644451 |
| 78 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.17171735 |
| 79 | chronic inflammatory response (GO:0002544) | 3.16679646 |
| 80 | innate immune response in mucosa (GO:0002227) | 3.16605755 |
| 81 | protein-lipid complex assembly (GO:0065005) | 3.16274918 |
| 82 | peptide hormone processing (GO:0016486) | 3.14232416 |
| 83 | phospholipid efflux (GO:0033700) | 3.11381972 |
| 84 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.11051049 |
| 85 | negative regulation of sterol transport (GO:0032372) | 3.10508925 |
| 86 | negative regulation of cholesterol transport (GO:0032375) | 3.10508925 |
| 87 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.06528313 |
| 88 | uronic acid metabolic process (GO:0006063) | 3.06136258 |
| 89 | glucuronate metabolic process (GO:0019585) | 3.06136258 |
| 90 | cell communication involved in cardiac conduction (GO:0086065) | 3.04473038 |
| 91 | sterol homeostasis (GO:0055092) | 3.01854495 |
| 92 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.01849269 |
| 93 | lipoprotein transport (GO:0042953) | 3.01294425 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.01061154 |
| 95 | regulation of cholesterol esterification (GO:0010872) | 3.00679445 |
| 96 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.00135738 |
| 97 | killing of cells of other organism (GO:0031640) | 2.99818721 |
| 98 | disruption of cells of other organism (GO:0044364) | 2.99818721 |
| 99 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.99563323 |
| 100 | GDP-mannose metabolic process (GO:0019673) | 2.98856541 |
| 101 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.97851771 |
| 102 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.96574402 |
| 103 | regulation of actin nucleation (GO:0051125) | 2.95697099 |
| 104 | amyloid precursor protein catabolic process (GO:0042987) | 2.95568002 |
| 105 | cellular glucuronidation (GO:0052695) | 2.94761993 |
| 106 | skeletal muscle adaptation (GO:0043501) | 2.94458953 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.92953791 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.92953791 |
| 109 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.92874424 |
| 110 | protein O-linked glycosylation (GO:0006493) | 2.92699074 |
| 111 | humoral immune response (GO:0006959) | 2.92449535 |
| 112 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.91324619 |
| 113 | regulation of triglyceride catabolic process (GO:0010896) | 2.90862351 |
| 114 | eosinophil chemotaxis (GO:0048245) | 2.90263945 |
| 115 | cholesterol transport (GO:0030301) | 2.83449669 |
| 116 | sterol transport (GO:0015918) | 2.83449669 |
| 117 | sphingomyelin metabolic process (GO:0006684) | 2.83213586 |
| 118 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.81621325 |
| 119 | transepithelial transport (GO:0070633) | 2.80792778 |
| 120 | regulation of systemic arterial blood pressure (GO:0003073) | 2.79876973 |
| 121 | mucosal immune response (GO:0002385) | 2.79690194 |
| 122 | muscle atrophy (GO:0014889) | 2.79336071 |
| 123 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.78382437 |
| 124 | negative regulation of viral release from host cell (GO:1902187) | 2.77448898 |
| 125 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.75878562 |
| 126 | regulation of proton transport (GO:0010155) | 2.74719731 |
| 127 | response to hydroperoxide (GO:0033194) | 2.74452961 |
| 128 | regulation of T cell tolerance induction (GO:0002664) | 2.74277923 |
| 129 | cholesterol efflux (GO:0033344) | 2.73929143 |
| 130 | regulation of viral entry into host cell (GO:0046596) | 2.73628549 |
| 131 | urea cycle (GO:0000050) | 2.73336507 |
| 132 | glucocorticoid metabolic process (GO:0008211) | 2.72609250 |
| 133 | fucosylation (GO:0036065) | 2.72546744 |
| 134 | purine nucleotide salvage (GO:0032261) | 2.72179313 |
| 135 | sulfate transport (GO:0008272) | 2.70916863 |
| 136 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.70491464 |
| 137 | protein neddylation (GO:0045116) | 2.69789592 |
| 138 | regulation of cGMP biosynthetic process (GO:0030826) | 2.69556485 |
| 139 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.69272691 |
| 140 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.69209809 |
| 141 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.68703076 |
| 142 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.68703076 |
| 143 | endocrine process (GO:0050886) | 2.68703076 |
| 144 | filopodium assembly (GO:0046847) | 2.68680086 |
| 145 | acute-phase response (GO:0006953) | 2.67927526 |
| 146 | regulation of vitamin metabolic process (GO:0030656) | 2.67564872 |
| 147 | positive regulation of vasodilation (GO:0045909) | 2.65716655 |
| 148 | ethanol oxidation (GO:0006069) | 2.63500061 |
| 149 | low-density lipoprotein particle remodeling (GO:0034374) | 2.62780099 |
| 150 | retina homeostasis (GO:0001895) | 2.60028156 |
| 151 | auditory receptor cell differentiation (GO:0042491) | 2.58555166 |
| 152 | glutathione biosynthetic process (GO:0006750) | 2.58239585 |
| 153 | urea metabolic process (GO:0019627) | 2.56258457 |
| 154 | eosinophil migration (GO:0072677) | 2.55922942 |
| 155 | androgen biosynthetic process (GO:0006702) | 2.54364671 |
| 156 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.52035825 |
| 157 | negative regulation of protein activation cascade (GO:2000258) | 2.51847114 |
| 158 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.48909579 |
| 159 | regulation of metalloenzyme activity (GO:0048552) | 2.48765364 |
| 160 | hormone catabolic process (GO:0042447) | 2.48693021 |
| 161 | phosphatidylserine metabolic process (GO:0006658) | 2.48405317 |
| 162 | negative regulation of hormone metabolic process (GO:0032351) | 2.48331932 |
| 163 | Golgi transport vesicle coating (GO:0048200) | 2.48199337 |
| 164 | COPI coating of Golgi vesicle (GO:0048205) | 2.48199337 |
| 165 | regulation of protein activation cascade (GO:2000257) | 2.46829537 |
| 166 | regulation of complement activation (GO:0030449) | 2.45596467 |
| 167 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.44484022 |
| 168 | progesterone metabolic process (GO:0042448) | 2.43717654 |
| 169 | nitric oxide biosynthetic process (GO:0006809) | 2.43396872 |
| 170 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.40529534 |
| 171 | regulation of keratinocyte proliferation (GO:0010837) | 2.40326231 |
| 172 | renal system process involved in regulation of blood volume (GO:0001977) | 2.40279820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.34127134 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.96247332 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.45385507 |
| 4 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.88229882 |
| 5 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.81789194 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.72230279 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.62706457 |
| 8 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.62413851 |
| 9 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.38797822 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.37672423 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.34353717 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.32799846 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.08637551 |
| 14 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.03135165 |
| 15 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.99699876 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.98919670 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.95906389 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.95044953 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.86954654 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.81913953 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81467607 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.80650320 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74246697 |
| 24 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.74099852 |
| 25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.73659463 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.69943218 |
| 27 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.69269818 |
| 28 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68130707 |
| 29 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.64837664 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63301154 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.58456100 |
| 32 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57670716 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53389668 |
| 34 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.50814551 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50676844 |
| 36 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.50391079 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.49879212 |
| 38 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.47191241 |
| 39 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42471799 |
| 40 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.42169796 |
| 41 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.39989969 |
| 42 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39442742 |
| 43 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.39088289 |
| 44 | ATF3_27146783_Chip-Seq_COLON_Human | 1.36434989 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36340777 |
| 46 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35345814 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34820455 |
| 48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34536775 |
| 49 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31656097 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.31413877 |
| 51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.30847878 |
| 52 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.30229341 |
| 53 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.30229341 |
| 54 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.30163250 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29992756 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.29646130 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29208392 |
| 58 | GATA2_19941826_ChIP-Seq_K562_Human | 1.27855978 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27078397 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23277504 |
| 61 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23033954 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19074619 |
| 63 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18971879 |
| 64 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.14558743 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13071388 |
| 66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07249574 |
| 67 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05385081 |
| 68 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04038683 |
| 69 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00695973 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00223521 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99250397 |
| 72 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97607956 |
| 73 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97027374 |
| 74 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96393388 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95627653 |
| 76 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95609737 |
| 77 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.95461557 |
| 78 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95417271 |
| 79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94442868 |
| 80 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.94286326 |
| 81 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93461186 |
| 82 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.92481373 |
| 83 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92347718 |
| 84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91668360 |
| 85 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.90977310 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90808229 |
| 87 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.90465178 |
| 88 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90280226 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90151553 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89789789 |
| 91 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87963131 |
| 92 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87676385 |
| 93 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87666230 |
| 94 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86896749 |
| 95 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86565629 |
| 96 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.86038489 |
| 97 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85649729 |
| 98 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.83276418 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82114702 |
| 100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81205621 |
| 101 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80333843 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80089474 |
| 103 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79327637 |
| 104 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.79198454 |
| 105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79023043 |
| 106 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.78470982 |
| 107 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77719719 |
| 108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77714028 |
| 109 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77559274 |
| 110 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.77125664 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76945767 |
| 112 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.76767233 |
| 113 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.75876250 |
| 114 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.75829036 |
| 115 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.73528874 |
| 116 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.73425564 |
| 117 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.73029042 |
| 118 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.72551457 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.69565054 |
| 120 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.69117838 |
| 121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.68965318 |
| 122 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.68376511 |
| 123 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.67504859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.37566742 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 7.36270989 |
| 3 | MP0001666_abnormal_nutrient_absorption | 5.07214898 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 4.59866351 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.27678788 |
| 6 | MP0003183_abnormal_peptide_metabolism | 2.98471052 |
| 7 | MP0000462_abnormal_digestive_system | 2.90035980 |
| 8 | MP0003866_abnormal_defecation | 2.78026053 |
| 9 | MP0000537_abnormal_urethra_morphology | 2.50570232 |
| 10 | MP0003252_abnormal_bile_duct | 2.48246224 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.34303684 |
| 12 | MP0003724_increased_susceptibility_to | 2.29133330 |
| 13 | MP0009840_abnormal_foam_cell | 2.27357841 |
| 14 | MP0001664_abnormal_digestion | 2.18585058 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.18234505 |
| 16 | MP0000538_abnormal_urinary_bladder | 2.17087600 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.11992768 |
| 18 | MP0010155_abnormal_intestine_physiology | 2.10091699 |
| 19 | MP0000465_gastrointestinal_hemorrhage | 2.04595710 |
| 20 | MP0001663_abnormal_digestive_system | 2.01557715 |
| 21 | MP0005381_digestive/alimentary_phenotyp | 1.95164784 |
| 22 | MP0001873_stomach_inflammation | 1.94690210 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 1.94271522 |
| 24 | MP0005365_abnormal_bile_salt | 1.94168289 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.93215491 |
| 26 | MP0006054_spinal_hemorrhage | 1.88375293 |
| 27 | MP0010678_abnormal_skin_adnexa | 1.87303519 |
| 28 | MP0001849_ear_inflammation | 1.84552169 |
| 29 | MP0004147_increased_porphyrin_level | 1.78394817 |
| 30 | MP0008004_abnormal_stomach_pH | 1.65835438 |
| 31 | MP0000477_abnormal_intestine_morphology | 1.64167379 |
| 32 | MP0001756_abnormal_urination | 1.52148743 |
| 33 | MP0002796_impaired_skin_barrier | 1.51324470 |
| 34 | MP0010386_abnormal_urinary_bladder | 1.51183160 |
| 35 | MP0003436_decreased_susceptibility_to | 1.48415562 |
| 36 | MP0005409_darkened_coat_color | 1.48180385 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.46093040 |
| 38 | * MP0002876_abnormal_thyroid_physiology | 1.42602573 |
| 39 | MP0005083_abnormal_biliary_tract | 1.41515905 |
| 40 | MP0008875_abnormal_xenobiotic_pharmacok | 1.40929165 |
| 41 | MP0000490_abnormal_crypts_of | 1.40505546 |
| 42 | MP0005387_immune_system_phenotype | 1.38623777 |
| 43 | MP0001790_abnormal_immune_system | 1.38623777 |
| 44 | MP0004947_skin_inflammation | 1.34123968 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.31352463 |
| 46 | MP0004019_abnormal_vitamin_homeostasis | 1.31204966 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.29961187 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.27502309 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.27184914 |
| 50 | MP0000604_amyloidosis | 1.24647478 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.21022408 |
| 52 | MP0009379_abnormal_foot_pigmentation | 1.19932401 |
| 53 | MP0004858_abnormal_nervous_system | 1.19899589 |
| 54 | MP0005377_hearing/vestibular/ear_phenot | 1.18300155 |
| 55 | MP0003878_abnormal_ear_physiology | 1.18300155 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.16807788 |
| 57 | MP0005310_abnormal_salivary_gland | 1.15690317 |
| 58 | MP0005025_abnormal_response_to | 1.15383218 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.13069982 |
| 60 | MP0002822_catalepsy | 1.09962486 |
| 61 | MP0005501_abnormal_skin_physiology | 1.09508779 |
| 62 | MP0005166_decreased_susceptibility_to | 1.07953990 |
| 63 | MP0003329_amyloid_beta_deposits | 1.07675918 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.03449447 |
| 65 | MP0002896_abnormal_bone_mineralization | 1.02688637 |
| 66 | MP0000470_abnormal_stomach_morphology | 0.99675769 |
| 67 | MP0001216_abnormal_epidermal_layer | 0.99444722 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 0.99420358 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 0.97461601 |
| 70 | MP0004043_abnormal_pH_regulation | 0.97274447 |
| 71 | MP0005448_abnormal_energy_balance | 0.95899017 |
| 72 | MP0003868_abnormal_feces_composition | 0.92473158 |
| 73 | MP0002098_abnormal_vibrissa_morphology | 0.91414653 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 0.90572221 |
| 75 | MP0001765_abnormal_ion_homeostasis | 0.90568771 |
| 76 | MP0000467_abnormal_esophagus_morphology | 0.90383500 |
| 77 | MP0005332_abnormal_amino_acid | 0.88602495 |
| 78 | MP0001764_abnormal_homeostasis | 0.85801281 |
| 79 | MP0002006_tumorigenesis | 0.84565550 |
| 80 | MP0004270_analgesia | 0.83575215 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83114852 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.82871900 |
| 83 | MP0008469_abnormal_protein_level | 0.82813836 |
| 84 | MP0001835_abnormal_antigen_presentation | 0.81822927 |
| 85 | MP0003303_peritoneal_inflammation | 0.81368840 |
| 86 | MP0002118_abnormal_lipid_homeostasis | 0.81137031 |
| 87 | MP0000609_abnormal_liver_physiology | 0.79766417 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 0.78670337 |
| 89 | MP0005164_abnormal_response_to | 0.77762348 |
| 90 | MP0000516_abnormal_urinary_system | 0.77298148 |
| 91 | MP0005367_renal/urinary_system_phenotyp | 0.77298148 |
| 92 | MP0002148_abnormal_hypersensitivity_rea | 0.77060095 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.77055162 |
| 94 | MP0000685_abnormal_immune_system | 0.76842135 |
| 95 | MP0002060_abnormal_skin_morphology | 0.75932710 |
| 96 | MP0000566_synostosis | 0.75555127 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.75434565 |
| 98 | MP0002909_abnormal_adrenal_gland | 0.75393839 |
| 99 | MP0002254_reproductive_system_inflammat | 0.75208590 |
| 100 | MP0005023_abnormal_wound_healing | 0.74706330 |
| 101 | MP0010307_abnormal_tumor_latency | 0.74311016 |
| 102 | MP0008775_abnormal_heart_ventricle | 0.74231961 |
| 103 | MP0009785_altered_susceptibility_to | 0.73961298 |
| 104 | MP0002132_abnormal_respiratory_system | 0.73957729 |
| 105 | MP0003075_altered_response_to | 0.72901442 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.72444250 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.71969771 |
| 108 | MP0006082_CNS_inflammation | 0.70922001 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.70537807 |
| 110 | MP0003315_abnormal_perineum_morphology | 0.69981561 |
| 111 | MP0008872_abnormal_physiological_respon | 0.69418400 |
| 112 | MP0000383_abnormal_hair_follicle | 0.69082883 |
| 113 | MP0000249_abnormal_blood_vessel | 0.68237267 |
| 114 | MP0000377_abnormal_hair_follicle | 0.67937207 |
| 115 | MP0001881_abnormal_mammary_gland | 0.67254632 |
| 116 | MP0005451_abnormal_body_composition | 0.66639873 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.66376645 |
| 118 | MP0000427_abnormal_hair_cycle | 0.64615574 |
| 119 | MP0009053_abnormal_anal_canal | 0.64439734 |
| 120 | MP0003045_fibrosis | 0.64082380 |
| 121 | MP0002234_abnormal_pharynx_morphology | 0.63406285 |
| 122 | MP0010771_integument_phenotype | 0.61972012 |
| 123 | MP0005248_abnormal_Harderian_gland | 0.58312642 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.57477340 |
| 125 | MP0004272_abnormal_basement_membrane | 0.55857880 |
| 126 | MP0003566_abnormal_cell_adhesion | 0.53607499 |
| 127 | MP0003283_abnormal_digestive_organ | 0.52675362 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.52243518 |
| 129 | MP0003950_abnormal_plasma_membrane | 0.51960721 |
| 130 | MP0005275_abnormal_skin_tensile | 0.51804425 |
| 131 | MP0005187_abnormal_penis_morphology | 0.50662810 |
| 132 | MP0001501_abnormal_sleep_pattern | 0.49104673 |
| 133 | MP0000579_abnormal_nail_morphology | 0.48752072 |
| 134 | MP0005165_increased_susceptibility_to | 0.47843179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 7.50919715 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.88353231 |
| 3 | Ileus (HP:0002595) | 6.68915954 |
| 4 | Onycholysis (HP:0001806) | 6.05432521 |
| 5 | Milia (HP:0001056) | 5.53405137 |
| 6 | Abnormality of proline metabolism (HP:0010907) | 5.35739356 |
| 7 | Hydroxyprolinuria (HP:0003080) | 5.35739356 |
| 8 | Fragile nails (HP:0001808) | 4.98200661 |
| 9 | Atrophic scars (HP:0001075) | 4.98095021 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.91726606 |
| 11 | Malnutrition (HP:0004395) | 4.31552031 |
| 12 | Steatorrhea (HP:0002570) | 4.09126407 |
| 13 | Exocrine pancreatic insufficiency (HP:0001738) | 4.08507862 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 4.08489152 |
| 15 | Pustule (HP:0200039) | 3.99025346 |
| 16 | Glomerulonephritis (HP:0000099) | 3.91593268 |
| 17 | Decreased circulating renin level (HP:0003351) | 3.90541960 |
| 18 | Acanthocytosis (HP:0001927) | 3.89830678 |
| 19 | Pili torti (HP:0003777) | 3.86981496 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 3.86326306 |
| 21 | Chronic diarrhea (HP:0002028) | 3.84806329 |
| 22 | Cupped ribs (HP:0000887) | 3.65785250 |
| 23 | Abdominal distention (HP:0003270) | 3.52921600 |
| 24 | Hypobetalipoproteinemia (HP:0003563) | 3.50805476 |
| 25 | Complement deficiency (HP:0004431) | 3.50586754 |
| 26 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.43920639 |
| 27 | Villous atrophy (HP:0011473) | 3.43598413 |
| 28 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.43598413 |
| 29 | Fat malabsorption (HP:0002630) | 3.38363735 |
| 30 | Abnormality of renin-angiotensin system (HP:0000847) | 3.36085381 |
| 31 | Abnormality of complement system (HP:0005339) | 3.35701237 |
| 32 | Plantar hyperkeratosis (HP:0007556) | 3.34506662 |
| 33 | * Goiter (HP:0000853) | 3.26131903 |
| 34 | Palpitations (HP:0001962) | 3.20045471 |
| 35 | Nephritis (HP:0000123) | 3.19086085 |
| 36 | Flat acetabular roof (HP:0003180) | 3.12888175 |
| 37 | Woolly hair (HP:0002224) | 3.12586718 |
| 38 | Myopathic facies (HP:0002058) | 3.02627404 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 2.98245604 |
| 40 | Abnormal tarsal ossification (HP:0008369) | 2.98230824 |
| 41 | Micronodular cirrhosis (HP:0001413) | 2.95196655 |
| 42 | Alkalosis (HP:0001948) | 2.94241046 |
| 43 | Progressive sensorineural hearing impairment (HP:0000408) | 2.90214478 |
| 44 | Dehydration (HP:0001944) | 2.84474309 |
| 45 | Curly hair (HP:0002212) | 2.69077556 |
| 46 | Ureteral stenosis (HP:0000071) | 2.67669214 |
| 47 | Vascular calcification (HP:0004934) | 2.66258944 |
| 48 | Renal salt wasting (HP:0000127) | 2.65338730 |
| 49 | Hypoplasia of dental enamel (HP:0006297) | 2.65014823 |
| 50 | Hemorrhage of the eye (HP:0011885) | 2.64257862 |
| 51 | Mesangial abnormality (HP:0001966) | 2.64129414 |
| 52 | Syncope (HP:0001279) | 2.64024746 |
| 53 | Abnormality of the 1st metacarpal (HP:0010009) | 2.63365821 |
| 54 | Metabolic alkalosis (HP:0200114) | 2.63010558 |
| 55 | Hyperglycinuria (HP:0003108) | 2.61779606 |
| 56 | Poikilocytosis (HP:0004447) | 2.61675408 |
| 57 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.61138320 |
| 58 | Pancreatitis (HP:0001733) | 2.59809505 |
| 59 | Cerebral palsy (HP:0100021) | 2.59393388 |
| 60 | Intrahepatic cholestasis (HP:0001406) | 2.58747487 |
| 61 | Abnormal pancreas size (HP:0012094) | 2.58506847 |
| 62 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.56765968 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.56554517 |
| 64 | Gastrointestinal dysmotility (HP:0002579) | 2.55558950 |
| 65 | Hyperactive renin-angiotensin system (HP:0000841) | 2.55171249 |
| 66 | Biliary tract neoplasm (HP:0100574) | 2.54633712 |
| 67 | Ureteral obstruction (HP:0006000) | 2.54572853 |
| 68 | Growth hormone excess (HP:0000845) | 2.53786342 |
| 69 | Hyperaldosteronism (HP:0000859) | 2.53333402 |
| 70 | Rectal prolapse (HP:0002035) | 2.46958458 |
| 71 | Vacuolated lymphocytes (HP:0001922) | 2.45944580 |
| 72 | Abnormality of the gastric mucosa (HP:0004295) | 2.44524603 |
| 73 | Ventricular tachycardia (HP:0004756) | 2.43620592 |
| 74 | Abnormality of vitamin B metabolism (HP:0004340) | 2.42389407 |
| 75 | Progressive hearing impairment (HP:0001730) | 2.41139133 |
| 76 | Increased IgE level (HP:0003212) | 2.40801009 |
| 77 | Cardiovascular calcification (HP:0011915) | 2.39722475 |
| 78 | Late onset (HP:0003584) | 2.37599629 |
| 79 | Abnormal hair laboratory examination (HP:0003328) | 2.36906605 |
| 80 | Gout (HP:0001997) | 2.35915206 |
| 81 | Abnormal biliary tract morphology (HP:0012440) | 2.35496088 |
| 82 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.33521458 |
| 83 | Hoarse voice (HP:0001609) | 2.32790995 |
| 84 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.31626757 |
| 85 | Pigmentary retinal degeneration (HP:0001146) | 2.31343299 |
| 86 | Fragile skin (HP:0001030) | 2.31013532 |
| 87 | Alopecia of scalp (HP:0002293) | 2.30115251 |
| 88 | Nail dystrophy (HP:0008404) | 2.22055200 |
| 89 | Esophageal varix (HP:0002040) | 2.21684665 |
| 90 | Hypolipoproteinemia (HP:0010981) | 2.21212616 |
| 91 | Glomerulosclerosis (HP:0000096) | 2.19280118 |
| 92 | Abnormality of vitamin metabolism (HP:0100508) | 2.18214842 |
| 93 | Hypotension (HP:0002615) | 2.15856231 |
| 94 | Mucopolysacchariduria (HP:0008155) | 2.14698539 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.14698539 |
| 96 | Nephrolithiasis (HP:0000787) | 2.12457702 |
| 97 | Abnormal foot bone ossification (HP:0010675) | 2.10797467 |
| 98 | Abnormality of macrophages (HP:0004311) | 2.10446684 |
| 99 | Abnormality of purine metabolism (HP:0004352) | 2.09766531 |
| 100 | Amyloidosis (HP:0011034) | 2.09728412 |
| 101 | Cervical subluxation (HP:0003308) | 2.09357970 |
| 102 | Abnormal blistering of the skin (HP:0008066) | 2.07102849 |
| 103 | Joint swelling (HP:0001386) | 2.06882902 |
| 104 | Reticulocytosis (HP:0001923) | 2.05445655 |
| 105 | Esophageal atresia (HP:0002032) | 2.05158020 |
| 106 | Glycosuria (HP:0003076) | 2.03411510 |
| 107 | Abnormality of urine glucose concentration (HP:0011016) | 2.03411510 |
| 108 | Amelogenesis imperfecta (HP:0000705) | 2.02024295 |
| 109 | Abnormal albumin level (HP:0012116) | 2.01313041 |
| 110 | Hypoalbuminemia (HP:0003073) | 2.01313041 |
| 111 | Increased mean platelet volume (HP:0011877) | 2.01235345 |
| 112 | Abnormality of the nasal mucosa (HP:0000433) | 2.00826243 |
| 113 | Focal segmental glomerulosclerosis (HP:0000097) | 2.00419906 |
| 114 | Hypoproteinemia (HP:0003075) | 1.99221619 |
| 115 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98565761 |
| 116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98565761 |
| 117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98565761 |
| 118 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.97333671 |
| 119 | Abnormality of carpal bone ossification (HP:0006257) | 1.94625154 |
| 120 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.94615371 |
| 121 | Hyperphosphatemia (HP:0002905) | 1.92712651 |
| 122 | Ventricular fibrillation (HP:0001663) | 1.92132819 |
| 123 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.91782178 |
| 124 | Symptomatic seizures (HP:0011145) | 1.91669026 |
| 125 | Abnormal glucose tolerance (HP:0001952) | 1.91560508 |
| 126 | Hyperparathyroidism (HP:0000843) | 1.91255958 |
| 127 | Hyperuricemia (HP:0002149) | 1.90080101 |
| 128 | Increased purine levels (HP:0004368) | 1.90080101 |
| 129 | Hyperammonemia (HP:0001987) | 1.89469006 |
| 130 | Ventricular arrhythmia (HP:0004308) | 1.89283231 |
| 131 | Cheilitis (HP:0100825) | 1.88603092 |
| 132 | Megaloblastic anemia (HP:0001889) | 1.88111386 |
| 133 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.87110472 |
| 134 | Short 1st metacarpal (HP:0010034) | 1.87110472 |
| 135 | Spontaneous abortion (HP:0005268) | 1.86742785 |
| 136 | Confusion (HP:0001289) | 1.86285475 |
| 137 | Xanthomatosis (HP:0000991) | 1.85627231 |
| 138 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.84195961 |
| 139 | Cone-rod dystrophy (HP:0000548) | 1.83673685 |
| 140 | Congenital sensorineural hearing impairment (HP:0008527) | 1.82774254 |
| 141 | Premature loss of primary teeth (HP:0006323) | 1.81675588 |
| 142 | Abnormality of chloride homeostasis (HP:0011422) | 1.80815715 |
| 143 | Uterine neoplasm (HP:0010784) | 1.80421179 |
| 144 | Dysostosis multiplex (HP:0000943) | 1.78732518 |
| 145 | Neoplasm of the small intestine (HP:0100833) | 1.78516814 |
| 146 | Facial diplegia (HP:0001349) | 1.76505079 |
| 147 | Flattened epiphyses (HP:0003071) | 1.75808561 |
| 148 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.74286047 |
| 149 | * Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.73708638 |
| 150 | Popliteal pterygium (HP:0009756) | 1.68590583 |
| 151 | Osteomyelitis (HP:0002754) | 1.67509510 |
| 152 | Gingival bleeding (HP:0000225) | 1.67194543 |
| 153 | Hypoglycemic coma (HP:0001325) | 1.66750382 |
| 154 | Abnormality of nucleobase metabolism (HP:0010932) | 1.66640368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.88701953 |
| 2 | MST4 | 5.87281379 |
| 3 | MST1R | 5.41118167 |
| 4 | EPHA2 | 4.09927386 |
| 5 | RIPK1 | 3.46142819 |
| 6 | NME1 | 3.24905081 |
| 7 | PIK3CA | 3.04434560 |
| 8 | LMTK2 | 3.02502723 |
| 9 | MAP2K2 | 2.98976048 |
| 10 | STK39 | 2.40445577 |
| 11 | EPHA3 | 2.39695515 |
| 12 | ACVR1B | 2.35157603 |
| 13 | PRKG2 | 2.25447429 |
| 14 | PTK6 | 2.15080818 |
| 15 | GRK6 | 2.13956639 |
| 16 | TESK1 | 2.07051224 |
| 17 | STK24 | 2.04073415 |
| 18 | MAP3K2 | 2.01795383 |
| 19 | MET | 2.00027524 |
| 20 | ERN1 | 1.73168087 |
| 21 | OXSR1 | 1.70324604 |
| 22 | EPHB2 | 1.68601040 |
| 23 | PRPF4B | 1.58828092 |
| 24 | STK10 | 1.56789668 |
| 25 | TAOK1 | 1.56209073 |
| 26 | FGFR3 | 1.49807231 |
| 27 | KSR2 | 1.46733849 |
| 28 | AKT3 | 1.45668534 |
| 29 | MAP3K10 | 1.40607602 |
| 30 | PTK2 | 1.39651589 |
| 31 | FER | 1.29967294 |
| 32 | PRKCI | 1.26295656 |
| 33 | RIPK4 | 1.23369665 |
| 34 | MAP2K1 | 1.23025617 |
| 35 | JAK1 | 1.22114846 |
| 36 | MYLK | 1.21398870 |
| 37 | CDC42BPA | 1.16460329 |
| 38 | EPHB1 | 1.14950275 |
| 39 | PAK4 | 1.09081845 |
| 40 | MAPKAPK3 | 1.06662340 |
| 41 | LIMK1 | 1.02066164 |
| 42 | ERBB4 | 1.01336891 |
| 43 | ZAP70 | 0.98915141 |
| 44 | MAP3K11 | 0.97575966 |
| 45 | MAP3K12 | 0.93756452 |
| 46 | BMX | 0.92418716 |
| 47 | DDR2 | 0.90461563 |
| 48 | TESK2 | 0.90193258 |
| 49 | MAP2K6 | 0.87087520 |
| 50 | MAP3K9 | 0.85527709 |
| 51 | IRAK1 | 0.83995265 |
| 52 | MAP3K8 | 0.83052707 |
| 53 | GRK1 | 0.81072483 |
| 54 | MAP3K1 | 0.80015192 |
| 55 | MAP3K7 | 0.77784218 |
| 56 | LRRK2 | 0.75873809 |
| 57 | CAMK2D | 0.75474339 |
| 58 | MATK | 0.71780212 |
| 59 | ERBB2 | 0.70062896 |
| 60 | CASK | 0.69369951 |
| 61 | PAK3 | 0.69348220 |
| 62 | MAP3K3 | 0.69048999 |
| 63 | MAP3K6 | 0.68105179 |
| 64 | NUAK1 | 0.65764002 |
| 65 | TGFBR2 | 0.65335613 |
| 66 | DMPK | 0.63578708 |
| 67 | LATS1 | 0.61705580 |
| 68 | TNIK | 0.59265923 |
| 69 | PKN2 | 0.56228243 |
| 70 | JAK3 | 0.54717894 |
| 71 | TBK1 | 0.53791386 |
| 72 | PRKAA2 | 0.53381550 |
| 73 | ICK | 0.49822056 |
| 74 | IKBKE | 0.47152479 |
| 75 | MAPK11 | 0.45119187 |
| 76 | SRC | 0.44922086 |
| 77 | MAPK7 | 0.44638547 |
| 78 | TYK2 | 0.44361201 |
| 79 | TAOK3 | 0.42000493 |
| 80 | TRIB3 | 0.41411268 |
| 81 | MAP4K1 | 0.41279103 |
| 82 | INSRR | 0.41012933 |
| 83 | HIPK2 | 0.40818386 |
| 84 | IGF1R | 0.40546571 |
| 85 | PDPK1 | 0.39566159 |
| 86 | BMPR2 | 0.38390959 |
| 87 | NLK | 0.37302545 |
| 88 | KIT | 0.37291985 |
| 89 | MELK | 0.36950764 |
| 90 | STK38L | 0.36652336 |
| 91 | PIM2 | 0.35931315 |
| 92 | IKBKB | 0.34717461 |
| 93 | CAMK2B | 0.34404449 |
| 94 | NEK6 | 0.33242236 |
| 95 | PRKCE | 0.33111421 |
| 96 | MAP3K14 | 0.32142490 |
| 97 | TTK | 0.31861946 |
| 98 | PAK1 | 0.31259042 |
| 99 | CAMK2G | 0.30699921 |
| 100 | TAOK2 | 0.30279350 |
| 101 | CSK | 0.29885385 |
| 102 | PDK2 | 0.29477967 |
| 103 | FGFR4 | 0.27802035 |
| 104 | PRKCA | 0.27543761 |
| 105 | PRKCZ | 0.27042601 |
| 106 | FGR | 0.26973512 |
| 107 | PDK1 | 0.26748562 |
| 108 | PRKAA1 | 0.26508109 |
| 109 | MAPKAPK2 | 0.25097929 |
| 110 | AURKB | 0.24842955 |
| 111 | DAPK2 | 0.24514840 |
| 112 | EEF2K | 0.23226722 |
| 113 | CDK6 | 0.23185807 |
| 114 | ROCK1 | 0.21908928 |
| 115 | ABL2 | 0.21738615 |
| 116 | SCYL2 | 0.20230980 |
| 117 | STK11 | 0.20103885 |
| 118 | FYN | 0.19812442 |
| 119 | PAK2 | 0.19637080 |
| 120 | PRKCD | 0.17291416 |
| 121 | STK3 | 0.17012906 |
| 122 | PDGFRA | 0.16770729 |
| 123 | ROCK2 | 0.16061100 |
| 124 | MAP3K13 | 0.15765126 |
| 125 | PRKACG | 0.14746923 |
| 126 | JAK2 | 0.12936930 |
| 127 | RET | 0.12439257 |
| 128 | CSNK1A1 | 0.12088600 |
| 129 | PDGFRB | 0.11159573 |
| 130 | RPS6KA1 | 0.11063458 |
| 131 | EGFR | 0.10980470 |
| 132 | DYRK1B | 0.10387649 |
| 133 | PRKCQ | 0.09815374 |
| 134 | PBK | 0.09718958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.29478090 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.47052127 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 3.99349872 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.75901979 |
| 5 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.56141643 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.28537119 |
| 7 | Bile secretion_Homo sapiens_hsa04976 | 2.74422287 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.59143516 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.40628297 |
| 10 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.31736776 |
| 11 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.97047829 |
| 12 | Galactose metabolism_Homo sapiens_hsa00052 | 1.89945774 |
| 13 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.79358325 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.74277929 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.71744444 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63484944 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.58855472 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.57355111 |
| 19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.53574985 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.52580245 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.52167918 |
| 22 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.46031069 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.43902357 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42518932 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.38198469 |
| 26 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.36204991 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33202333 |
| 28 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.32564855 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.31160927 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27604076 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.27323966 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.22984670 |
| 33 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.20587581 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20384433 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.17690936 |
| 36 | Tight junction_Homo sapiens_hsa04530 | 1.14672523 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.07403104 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.07059869 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07014638 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.05159702 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04800900 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01424438 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95161062 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 0.94541395 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93611191 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90152137 |
| 47 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88219089 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86200943 |
| 49 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.85447689 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84216539 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 0.77509652 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76666845 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76424767 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76341655 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75055269 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72866277 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72511142 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71623421 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70968706 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68725608 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68282522 |
| 62 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.67791742 |
| 63 | Adherens junction_Homo sapiens_hsa04520 | 0.67518831 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67286099 |
| 65 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65568085 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64091759 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63287046 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63247107 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62589440 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.60922102 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60181677 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.56809738 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.56263497 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55840925 |
| 75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55612390 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52472066 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51297876 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.49739973 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48292859 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.48095723 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45836003 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44524673 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.43505229 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.43291822 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42823894 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41985901 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.41162121 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40764351 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39905923 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37062140 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36384218 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35273775 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34963970 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.34483357 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34318652 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33480363 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33371317 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33089642 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33080691 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32956969 |
| 101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.32394712 |
| 102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30912403 |
| 103 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29513003 |
| 104 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29133118 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.27304378 |
| 106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.26914438 |
| 107 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.26532953 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.25245519 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.23488774 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.22059119 |
| 111 | Long-term depression_Homo sapiens_hsa04730 | 0.22041716 |
| 112 | Renin secretion_Homo sapiens_hsa04924 | 0.21784834 |
| 113 | Influenza A_Homo sapiens_hsa05164 | 0.21774356 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21709384 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.20654086 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.19390418 |
| 117 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.18880325 |
| 118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.18867280 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.17888411 |
| 120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.17755998 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.16613824 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16253085 |
| 123 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.16110360 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.15760600 |
| 125 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.15470706 |
| 126 | Retinol metabolism_Homo sapiens_hsa00830 | 0.14564422 |
| 127 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.13023158 |
| 128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.12672065 |
| 129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.11911724 |
| 130 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.11662187 |

